The point is that it is early in the day, and the TPP locks us into this five plus three, or eight. If we identify over time—and perhaps we will develop a strong biologics sector—we may find, as a country, that in fact the eight is not suiting us well. The TPP locks us in.
Even our major trading partner has recognized it, and many of the other TPP countries. They come at this from many different perspectives. Why reach an agreement and lock us into a particular policy today, the very paradigm of innovation in that sector, when we simply don't know what the optimal length of protection is?